Novo Nordisk to build $220 mln raw materials plant in Denmark

Novo Nordisk's (NOVOb.CO) Pharmatech unit will build a 1.5 billion Danish crown ($221 million) plant in Denmark to meet significantly higher demand for medicines to fight chronic diseases, the company said on Friday.